Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 2 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Recs

0
Player Avatar angel100423 (< 20) Submitted: 7/4/2012 10:44:30 AM : Outperform Start Price: $9.99 ARNA Score: -43.22

this is the first obese drug out there and people in real need will be treated to this drug, i am sure they can't wait

Featured Broker Partners


Advertisement